178 related items for PubMed ID: 20304183
1. Prevalence of posttransplantation lymphoproliferative disease in pediatric liver transplant recipients.
Wiederkehr JC, Coelho IM, Avilla SG, e Silva EM, Schuller S, Ouno DD, Wiederkehr BA, Polimeni M.
Transplant Proc; 2010 Mar; 42(2):521-2. PubMed ID: 20304183
[Abstract] [Full Text] [Related]
2. Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience.
Pinho-Apezzato ML, Tannuri U, Tannuri AC, Mello ES, Lima F, Gibelli NE, Santos MM, Ayoub AA, Maksoud-Filho JG, Velhote MC, Silva MM, Andrade WC, Miyatani HT.
Transplant Proc; 2010 Jun; 42(5):1763-8. PubMed ID: 20620519
[Abstract] [Full Text] [Related]
3. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[Abstract] [Full Text] [Related]
4. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation.
Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH.
Transplant Proc; 2004 Oct; 36(8):2307-8. PubMed ID: 15561231
[Abstract] [Full Text] [Related]
5. Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.
Transplant Proc; 2006 Apr; 38(3):930-1. PubMed ID: 16647513
[Abstract] [Full Text] [Related]
6. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
[Abstract] [Full Text] [Related]
7. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
[Abstract] [Full Text] [Related]
8. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A.
Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010
[Abstract] [Full Text] [Related]
9. Posttransplant lymphoproliferative disorder in pediatric liver transplantation.
Uribe M, Hunter B, Alba A, Calabrán L, Flores L, Soto P, Herzog C.
Transplant Proc; 2009 Jun 15; 41(6):2679-81. PubMed ID: 19716000
[Abstract] [Full Text] [Related]
10. Posttransplantation growth in pediatric liver recipients.
Renz JF, de Roos M, Rosenthal P, Mudge C, Bacchetti P, Watson J, Roberts JP, Ascher NL, Emond JC.
Liver Transpl; 2001 Dec 15; 7(12):1040-55. PubMed ID: 11753906
[Abstract] [Full Text] [Related]
11. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F, Kunitake H, Laks H, Odim J.
Pediatr Transplant; 2006 Feb 15; 10(1):60-6. PubMed ID: 16499589
[Abstract] [Full Text] [Related]
12. Liver transplantation for children: Red Cross Children's Hospital experience.
Spearman CW, McCulloch M, Millar AJ, Burger H, Numanoglu A, Goddard E, Cooke L, Cywes S, Rode H, Kahn D.
Transplant Proc; 2005 Mar 15; 37(2):1134-7. PubMed ID: 15848647
[Abstract] [Full Text] [Related]
13. Development of lymphoproliferative disease after liver transplantation.
Marqués E, Jiménez C, Manrique A, Vallejo GH, Clemares M, Ortega P, Moreno E.
Transplant Proc; 2008 Nov 15; 40(9):2988-9. PubMed ID: 19010169
[Abstract] [Full Text] [Related]
14. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
[Abstract] [Full Text] [Related]
15. Posttransplant lymphoproliferative disorders in transplant recipients.
Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
Transplant Proc; 2006 Mar 15; 38(2):641-5. PubMed ID: 16549195
[Abstract] [Full Text] [Related]
16. Sirolimus in pediatric liver transplantation: a single-center experience.
Gibelli NE, Tannuri U, Pinho-Apezzato ML, Tannuri AC, Maksoud-Filho JG, Andrade WC, Velhote MC, Santos MM, Ayoub AA, Marques da Silva M.
Transplant Proc; 2009 Apr 15; 41(3):901-3. PubMed ID: 19376384
[Abstract] [Full Text] [Related]
17. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
Deng Z, Jiang L, Zhou T, Shen C, Chen Q, Xia Q.
Zhonghua Er Ke Za Zhi; 2014 Aug 15; 52(8):579-82. PubMed ID: 25224233
[Abstract] [Full Text] [Related]
18. The changing face of post-transplant lymphoproliferative disease in the era of molecular EBV monitoring.
Kerkar N, Morotti RA, Madan RP, Shneider B, Herold BC, Dugan C, Miloh T, Karabicak I, Strauchen JA, Emre S.
Pediatr Transplant; 2010 Jun 15; 14(4):504-11. PubMed ID: 20070559
[Abstract] [Full Text] [Related]
19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J.
Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091
[Abstract] [Full Text] [Related]
20. Outcome of pediatric liver transplant recipients in Turkey: single center experience.
Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, Yagci RV, Tokat Y.
Pediatr Transplant; 2005 Dec 15; 9(6):723-8. PubMed ID: 16269042
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
